Intravenous adrenaline for shock in neonates

Area of Science:

• Neonatal Resuscitation
• Pediatric Cardiology
• Clinical Pharmacology

Background:

• Dopamine and dobutamine are commonly used for neonatal shock with inconsistent outcomes.
• Birth asphyxia is a critical condition leading to shock in newborns.
• Refractory shock requires alternative therapeutic strategies.

Purpose of the Study:

• To evaluate the safety and efficacy of adrenaline as an add-on therapy.
• To investigate adrenaline's role in neonatal shock refractory to standard catecholamines.
• To analyze outcomes in neonates with birth asphyxia and shock treated with adrenaline.

Main Methods:

• Retrospective data analysis of 20 neonates.
• Inclusion criteria: neonates with birth asphyxia and shock refractory to dopamine and dobutamine.
• Treatment group received add-on adrenaline therapy.

Main Results:

• Adrenaline was administered to 20 neonates with refractory shock.
• No significant adverse events were reported, indicating a favorable safety profile.
• Adrenaline demonstrated effectiveness in managing shock in this cohort.

Conclusions:

• Adrenaline is a safe and effective add-on therapy for neonatal shock.
• It provides a viable option for cases unresponsive to dopamine and dobutamine.
• This study supports the use of adrenaline in managing severe neonatal shock secondary to birth asphyxia.